ERK and p38 MAPK activate cell growth and invasive ability in bladder cancer cells.36, 37 In our results presented protein levels of MMP‐9, XIAP, VEGF, and Cyclin‐D1 were significantly reduced by PD98059 or SB203580 treatment, respectively. This evidence concerns the gene MMP9 and urinary bladder cancer.